Novartis Pharma AG

Suisse


Commandez votre montre hebdomadaire Novartis Pharma AG
Quantité totale PI 102
Quantité totale incluant filiales 102 (+ 0 pour les filiales)
Rang # Quantité totale PI 13 165
Note d'activité PI 2,7/5.0    54
Rang # Activité PI 13 279
Parent Novartis AG
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

67 13
3 0
17 2
0
 
Dernier brevet 2025 - Substituted indole compounds and...
Premier brevet 1988 - Method and apparatus for the man...
Dernière marque 2025 - KNOW RLT
Première marque 2003 - TYKERB

Filiales

2 subsidiaries with IP (0 patents, 0 trademarks)

1 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Providing information about medical and scientific research via a website Providing health inform...
P/S Medical research services; Pharmaceutical research services; Pharmaceutical research and development
P/S Pharmaceutical preparations.
Invention Substituted indole compounds and methods of use thereof. Provided herein are substituted indole ...
Invention Compounds and compositions for treating conditions associated with sting activity. This disclosur...
2024 Invention Compounds and compositions for treating conditions associated with sting activity. This disclosu...
2023 Invention Solid forms of complement factor b inhibitors. The present disclosure relates to crystalline form...
2022 Invention Oxalamide compounds and compositions for treating conditions associated with sting activity. Thi...
2021 Invention Methods of treating cancer. Provided herein are methods of treating a subject, such as a subject...
Invention Method of treating psma-expressing cancers. The present invention relates to combinations for use...
Invention Dose and regimen for an hdm2-p53 interaction inhibitor in hematological tumors. The present inve...
Invention Il-17a/f heterologous polypeptides and therapeutic uses thereof. The present invention is direct...
Invention Substituted pyrazolyl compounds and methods of use thereof. Provided herein are compounds, compo...
2016 P/S Provision of medical information, including the results of clinical studies, for doctors and pat...
2013 P/S providing healthcare information to patients and healthcare professionals via the internet
2011 P/S Pharmaceutical preparations and substances for the treatment of oncological related diseases and ...
2010 P/S Pharmaceutical preparations and substances for the treatment of [ infectious diseases, blood diso...
2007 P/S PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER
P/S printed educational materials, namely, brochures and pamphlets concerning cancer and cancer treat...
2006 P/S pharmaceutical preparations for human use for the treatment and prevention of thrombocytopenia an...
2005 P/S PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF VIRAL AND ONCOLOGICAL RELATED DIS...
2003 P/S Pharmaceutical preparations for the treatment of cancer[, infectious diseases, pain, inflammation...